SEATTLE, Sept. 30 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
(CTI) (Nasdaq and MTA: CTIC) will host an investor and media day in Milan,
Italy on October 3, 2008. The investor day will provide an update from
executive management on key strategic initiatives and regulatory milestones
for the Company. Additionally, Alessandro Gianni, M.D., Director of the
School of Specialization in Medical Oncology at the University of Milan,
who has authored over 300 publications will be a guest speaker at the event
and will provide a key perspective on the benefits of Zevalin(R)
(([90Y]-ibritumomab tiuxetan) in the treatment of follicular non-Hodgkin's
lymphoma. The meeting is an invitation-only event. A webcast and live
teleconference of the event is available to all investors.
Webcast and Teleconference Details
Date: Friday, October 3, 2008
Time: 7:00 a.m. Eastern/1:00 p.m. Central European/4:00 a.m. Pacific Time
Conference Call Numbers
1-866-239-6425 (US Participants)
+39 02 80 20 911 (Italy)
+44 208 7929 750 (Europe)
Call-back numbers for post-listening
1-866-848-9310 (US Participants)
+39 02 80 61 3780 (Italy)
+44 207 1086 235 (Europe)
Live audio webcast at http://www.celltherapeutics.com will be archived for post listening approximately two hours after call ends.
About Cell Therapeutics, Inc.
Headquartered in Seattle, CTI is a biopharmaceutical company committed
to developing an integrated portfolio of oncology products aimed at making
cancer more treatable. For additional information, please visit
T : 206.272.4347
F : 206.272.4434
|SOURCE Cell Therapeutics, Inc.|
Copyright©2008 PR Newswire.
All rights reserved